Breaking News Instant updates and real-time market news.

NXPI

NXP Semiconductors

$102.82

-1.18 (-1.13%)

, QCOM

Qualcomm

$50.27

-0.53 (-1.04%)

20:10
05/02/18
05/02
20:10
05/02/18
20:10

NXP Semiconductors reports Q1 EPS 17c, may not compare to consensus $1.68

Reports Q1 revenue $2.27B, consensus $2.35B. Q1 operating margin 27.2% vs. 27.1% last year. The company states: "We continue to believe that our transaction with Qualcomm is important to supporting our customers' long term requirements in both autonomous driving and secure IoT given our complimentary product portfolios, Qualcomm's strength in connectivity and high end processing. On April 19th, NXP agreed with Qualcomm to an extension of the purchase agreement to facilitate the final needed regulatory approval by the Ministry of Commerce of the Government of China, the last remaining regulatory requirement as all other regulatory authorities have cleared more than three and a half months ago. Once all required regulatory approvals are obtained, the companies can execute the final tender offer process to complete the transaction. Finally, I would like to personally thank all our employees for their focus and significant effort they have invested to assure NXP's success and to thank all our customers for their commitment to NXP."

NXPI

NXP Semiconductors

$102.82

-1.18 (-1.13%)

QCOM

Qualcomm

$50.27

-0.53 (-1.04%)

NXPI NXP Semiconductors
$102.82

-1.18 (-1.13%)

04/24/18
RBCM
04/24/18
NO CHANGE
Target $75
RBCM
Outperform
Qualcomm price target lowered to $75 from $80 at RBC Capital
RBC Capital analyst Amit Daryanani lowered his price target on Qualcomm (QCOM) to $75 ahead of the company's earnings tomorrow, citing his supply chain conversations suggesting a "muted" iPhone (AAPL) and Samsung (SSNLF) GS9 unit shipment growth along with lackluster smartphone demand in China. Longer term, the analyst keeps his Outperform rating on Qualcomm with a view toward potential catalysts being "licensing resolution", the close of NXP Semiconductors (NXPI) deal or a "material buyback, and cost reductions.
04/26/18
SBSH
04/26/18
NO CHANGE
Target $56
SBSH
Neutral
Qualcomm royalty rates will continue to decline, says Citi
Citi analyst Christopher Danely views Qualcomm's fiscal Q2 results as "OK" but notes the company lowered its guidance. The analyst believes royalty rates, which represent roughly two-thirds of earnings, will continue to decline at Qualcomm and that the possible NXP Semiconductors (NXPI) deal "may be fraught with problems." Further, if Apple (AAPL) wins the lawsuit, Qualcomm's earnings could be reduced by up to 56%, Danely tells investors in a research note. He reiterates a Neutral rating on Qualcomm and lowered his price target for the shares to $56 from $58.
04/27/18
RHCO
04/27/18
UPGRADE
RHCO
Buy
NXP Semiconductors upgraded to Buy from Hold at SunTrust
04/27/18
RHCO
04/27/18
UPGRADE
Target $121
RHCO
Buy
NXP Semiconductors upgraded to Buy at SunTrust on attractive price entry
As reported earlier, SunTrust analyst William Stein upgraded NXP Semiconductors (NXPI) to Buy, saying that the selloff from the re-filing by Qualcomm (QCOM) for its acquisition with China's Commerce Ministry has taken the stock to "compelling" levels. The analyst contends that even if the deal does not close, the company's stand-alone value is modeled at $121, implying an 18% return from the current level. Stein lowers his price target to $121 from $127.50 as part of his upgrade but sees the "bull case" scenario leading to $135 stock price .
QCOM Qualcomm
$50.27

-0.53 (-1.04%)

04/26/18
BMOC
04/26/18
NO CHANGE
Target $55
BMOC
Market Perform
Qualcomm price target lowered to $55 from $70 at BMO Capital
BMO Capital analyst Tim Long lowered his price target on Qualcomm (QCOM) to $55 and kept his Market Perform rating. Long says that despite the "favorable" Q2 results, the company announced "much weaker" guidance for the June quarter, noting that while the chip business continues to deliver, the "outlook for royalties is negative". Aside from the ongoing disputes with Apple (AAPL) and Huawei, the analyst points to reduced royalty rates from other licensees, including a lower effective rate from Samsung (SSNLF). Long prefers a neutral stance amid the "ongoing uncertainty around licensing, as well as multiple regulatory investigations".

TODAY'S FREE FLY STORIES

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
11/19/18
11/19
08:16
11/19/18
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$50.94

0.89 (1.78%)

, FCX

Freeport McMoRan

$11.96

(0.00%)

08:16
11/19/18
11/19
08:16
11/19/18
08:16
Periodicals
Governments demand more cash from large mining companies, WSJ reports »

As mineral prices rise,…

RIO

Rio Tinto

$50.94

0.89 (1.78%)

FCX

Freeport McMoRan

$11.96

(0.00%)

ABX

Barrick Gold

$13.04

0.05 (0.38%)

FQVLF

First Quantum Minerals

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMC

Altra Industrial Motion

, FTV

Fortive

$75.45

-0.28 (-0.37%)

08:15
11/19/18
11/19
08:15
11/19/18
08:15
Recommendations
Altra Industrial Motion, Fortive analyst commentary  »

Altra Industrial Motion…

AIMC

Altra Industrial Motion

FTV

Fortive

$75.45

-0.28 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

CCJ

Cameco

08:15
11/19/18
11/19
08:15
11/19/18
08:15
Upgrade
Cameco rating change  »

Cameco upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAAS

Pan American Silver

$12.99

0.125 (0.97%)

08:15
11/19/18
11/19
08:15
11/19/18
08:15
Downgrade
Pan American Silver rating change  »

Pan American Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
11/19/18
11/19
08:15
11/19/18
08:15
General news
Fedspeak from NY Fed moderate Williams »

Fedspeak from NY Fed…

CPTA

Capitala Finance

$8.06

0.03 (0.37%)

08:11
11/19/18
11/19
08:11
11/19/18
08:11
Hot Stocks
Capitala Group invests in Visible Body »

Capitala Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$28.13

-0.05 (-0.18%)

08:11
11/19/18
11/19
08:11
11/19/18
08:11
Hot Stocks
eBay announces Black Friday, Cyber Monday deals »

eBay is kicking off eight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

RGLS

Regulus

$1.42

0.1 (7.58%)

08:09
11/19/18
11/19
08:09
11/19/18
08:09
Hot Stocks
Regulus presents new data on anti-miR candidate for treatment of GBM »

Regulus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVZMY

Novozymes

$0.00

(0.00%)

08:09
11/19/18
11/19
08:09
11/19/18
08:09
Conference/Events
Novozymes to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCLI

BrainStorm

$3.17

0.02 (0.63%)

08:08
11/19/18
11/19
08:08
11/19/18
08:08
Hot Stocks
BrainStorm submits IND to FDA for NurOwn »

BrainStorm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BE

Bloom Energy

$16.04

0.56 (3.62%)

08:08
11/19/18
11/19
08:08
11/19/18
08:08
Hot Stocks
Bloom Energy enters strategic partnership with SK E&C »

SK Group and Bloom Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

DRRX

Durect

$0.91

-0.0094 (-1.02%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Hot Stocks
Durect amends ongoing Phase 2a trial of DUR-928 »

Durect announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACI

CACI

$180.35

-0.03 (-0.02%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Hot Stocks
CACI awarded $413M contract for U.S. Army communications systems support »

CACI International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLND

Talend

$37.44

-1.13 (-2.93%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Recommendations
Talend analyst commentary  »

Talend price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

MGTA

Magenta Therapeutics

$7.50

0.4 (5.63%)

08:06
11/19/18
11/19
08:06
11/19/18
08:06
Hot Stocks
Magenta Therapeutics names Jason Ryan as Chief Operating and Financial Officer »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

NERV

Minerva

$8.41

0.11 (1.33%)

08:06
11/19/18
11/19
08:06
11/19/18
08:06
Hot Stocks
Minerva announces results from roluperidone study »

Minerva announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BKI

Black Knight

$49.77

0.87 (1.78%)

, DNB

Dun & Bradstreet

$142.27

0.11 (0.08%)

08:05
11/19/18
11/19
08:05
11/19/18
08:05
Hot Stocks
Black Knight board approves $375M investment in Dun & Bradstreet »

Black Knight (BKI)…

BKI

Black Knight

$49.77

0.87 (1.78%)

DNB

Dun & Bradstreet

$142.27

0.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 03

    Dec

CMP

Compass Minerals

$52.49

0.98 (1.90%)

08:04
11/19/18
11/19
08:04
11/19/18
08:04
Hot Stocks
Compass Minerals CEO to step down, Dick Grant named interim CEO »

Compass Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LANC

Lancaster Colony

$182.53

-0.21 (-0.11%)

08:03
11/19/18
11/19
08:03
11/19/18
08:03
Hot Stocks
Lancaster Colony acquires assets of Omni Baking Company for $25M »

Lancaster Colony…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TENX

Tenax Therapeutics

$3.80

(0.00%)

08:03
11/19/18
11/19
08:03
11/19/18
08:03
Hot Stocks
Tenax activates first clinical research site for Phase 2 trial of levosimendan »

Tenax Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLDB

Solid Biosciences

$33.82

2.81 (9.06%)

, SRPT

Sarepta

$119.02

0.14 (0.12%)

08:02
11/19/18
11/19
08:02
11/19/18
08:02
Conference/Events
Morgan Stanley to hold a bus trip »

Biotech Boston Bus Trip…

SLDB

Solid Biosciences

$33.82

2.81 (9.06%)

SRPT

Sarepta

$119.02

0.14 (0.12%)

NTGN

Neon Therapeutics

$6.98

-0.1 (-1.41%)

EDIT

Editas Medicine

$29.00

0.92 (3.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NEE

NextEra Energy

$180.41

1.27 (0.71%)

08:02
11/19/18
11/19
08:02
11/19/18
08:02
Hot Stocks
NextEra Energy Transmission to acquire Trans Bay Cable for approximately $1B »

NextEra Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

KMB

Kimberly-Clark

$111.22

0.43 (0.39%)

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Periodicals
Kimberly-Clark won't sell European tissue business with bids too low, FT says »

Kimberly-Clark will call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Conference/Events
Bernstein to hold a symposium »

5th Annual Asset…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.